Biogen, Inc. (BIIB)

191.53 -0.55 (-0.29%) USD  |  NASDAQ  |  Feb 20, 14:01
More

Biogen Consensus Recommendation

Consensus Recommendation Chart

View Consensus Recommendation for BIIB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Consensus Recommendation Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Consensus Recommendation Range, Past 5 Years

View Consensus Recommendation Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Consensus Recommendation Benchmarks

View Consensus Recommendation Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
Merck & Co., Inc. Upgrade
AbbVie, Inc. Upgrade
Stoke Therapeutics, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade